Antibodies of angiogenesis inhibiting domains of CD148

Details for Australian Patent Application No. 2005249381 (hide)

Owner Amgen, Inc.

Inventors Kariv, Revital; Fanslow, William C. III; Smothers, James F.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005249381

PCT Pub. Number WO2005/117970

Priority 60/585,686 06.07.04 US; 60/564,885 23.04.04 US; 60/565,158 23.04.04 US; 60/571,566 14.05.04 US

Filing date 22 April 2005

Wipo publication date 15 December 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/117970 Priority application(s): WO2005/117970

25 January 2007 Change of Name(s) of Applicant(s), Section 104

  Amgen, Inc. The name of the applicant has been changed to Amgen Inc.

9 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249382-Monocyclic heterocycles as kinase inhibitors

2005249380-Kinase modulators and methods of use